Show simple item record

dc.contributor.authorZipf, Nathan
dc.contributor.authorGrant, Lauren
dc.contributor.authorRobinson, Brent
dc.contributor.authorTeasdale, Trudy
dc.contributor.authorGrant, Gary
dc.contributor.authorHattingh, H Laetitia
dc.date.accessioned2021-09-16T04:31:53Z
dc.date.available2021-09-16T04:31:53Z
dc.date.issued2021
dc.identifier.issn2210-7703
dc.identifier.doi10.1007/s11096-021-01307-1
dc.identifier.urihttp://hdl.handle.net/10072/408067
dc.description.abstractBackground Insulin is a high-risk medicine, associated with hospital medication errors. Pharmacists play an important role in the monitoring of patients on insulin. Objective To analyse interventions made by hospital pharmacists that were associated with insulin prescribing for inpatients with diabetes. Method Retrospective audit of pharmacist interventions for adult inpatients for an 8-month period, 1 June 2019–31 January 2020. Pharmacist interventions recorded in the electronic medication management system by inpatient unit and dedicated high-risk medicine pharmacists were extracted, screened, and analysed. Results Of 3975 pharmacist interventions 3356 (84.43%) were recorded by high-risk medicine pharmacists and 619 (15.57%) by inpatient unit pharmacists. July and August 2019 had the highest numbers of interventions with 628 and 643 (15.80 and 16.18%) respectively. Most of the interventions, namely 3410 (85.79%) were classified as medicine optimisation interventions and 565 (14.21%) as prescribing errors. In the medicine optimisation intervention category, 2985 (75.09%) were due to insulin not charted for ongoing administration. Conclusion This study provides insights into pharmacist interventions for inpatients on insulin, showing that high-risk medicine pharmacists recorded most interventions. The classification of the insulin interventions into medicine optimisation and prescribing errors provides useful information for the training of prescribers in insulin management.
dc.description.peerreviewedYes
dc.languageEnglish
dc.publisherSpringer
dc.relation.ispartofjournalInternational Journal of Clinical Pharmacy
dc.subject.fieldofresearchClinical sciences
dc.subject.fieldofresearchBasic pharmacology
dc.subject.fieldofresearchEndocrinology
dc.subject.fieldofresearchPharmacology and pharmaceutical sciences
dc.subject.fieldofresearchOther health sciences
dc.subject.fieldofresearchcode3202
dc.subject.fieldofresearchcode321401
dc.subject.fieldofresearchcode320208
dc.subject.fieldofresearchcode3214
dc.subject.fieldofresearchcode4299
dc.subject.keywordsScience & Technology
dc.subject.keywordsLife Sciences & Biomedicine
dc.subject.keywordsPharmacology & Pharmacy
dc.subject.keywordsElectronic prescribing
dc.subject.keywordsHigh-risk medicine
dc.titleAnalysis of inpatient and high-risk medicine pharmacist interventions associated with insulin prescribing for hospital inpatients with diabetes
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationZipf, N; Grant, L; Robinson, B; Teasdale, T; Grant, G; Hattingh, HL, Analysis of inpatient and high-risk medicine pharmacist interventions associated with insulin prescribing for hospital inpatients with diabetes,International Journal of Clinical Pharmacy, 2021
dcterms.dateAccepted2021-07-03
dc.date.updated2021-09-13T04:38:29Z
gro.description.notepublicThis publication has been entered as an advanced online version in Griffith Research Online.
gro.hasfulltextNo Full Text
gro.griffith.authorGrant, Gary D.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record